Shenzhen Yuanxing Gene Technology Co., Ltd, its predecessor is Shenzhen Yuanxing Biopharmaceutical Technology Co. Ltd. gene drug R & D center, founded in 2004, focuses on the development, production and outsourcing services of virus vector (including Adenovirus, Lentivirus, Poxviruses, Herpesvirus, Adeno-associated Virus, etc.) gene therapy drug and gene vaccines.
Yuanxing gene has established an advanced scale-preparation technology platform of viral vector gene therapy product, and develop a series of gene therapy products and gene vaccine for tumor, chronic infection disease and inherited metabolic disorders based on the platform.Yuanxing gene built 1600m2 clean workshop, meeting the national GMP requirements, including bulk production department, preparation production department and quality control laboratory, equipped with international advanced equipment, with professional R & D team, with the R & D capacity including virus assessment, pilot test, pilot scale production, clinical sample production, clinical application, project management, GMP quality management,and so on, meeting the requirements of the R & D, production and quality control of virus vector drug. The level of Yuanxing’s scale-preparation production technology of virus vector drug is in the lead level. The yield and quality can meet the preparation requirements of virus vector drug for preclinical and clinical trials.